A protein linked to ALS and dementia, TDP43, plays a crucial role in regulating DNA mismatch repair, a process vital for maintaining genetic information and cellular health. This discovery, published in Nucleic Acids Research, could significantly impact our understanding of cancer and neurodegeneration. The study reveals that TDP43 regulates genes responsible for fixing DNA mistakes. When this protein is absent or overproduced, these repair genes become hyperactive, causing damage to neurons and genome instability, potentially leading to cancer. This finding is particularly relevant for diseases like ALS and frontotemporal dementia (FTD), where TDP43 dysfunction is common.
The research team also uncovered a connection between TDP43 and cancer. By analyzing extensive cancer datasets, they found that high levels of TDP43 correlate with increased mutation rates. This suggests that TDP43's role extends beyond ALS and FTD, as it appears to be upregulated in cancers, contributing to a higher mutation load. This overlap between neurodegeneration and cancer makes TDP43 a critical player in two of the most pressing health challenges of our time.
The study's authors suggest that reducing overactive DNA repair in lab models partially reversed damage caused by TDP43 issues, opening up new treatment possibilities. Controlling DNA mismatch repair could be a promising therapeutic strategy. The research team included Vincent Provasek, Suganya Rangaswamy, Manohar Kodavati, Joy Mitra, Vikas Malojirao, Velmarini Vasquez, Gavin Britz, and Sankar Mitra from Houston Methodist, as well as collaborators from MD Anderson Cancer Center, the University of Massachusetts, UT Southwestern Medical Center, and Binghamton University.
The study was primarily funded by the National Institute of Neurological Disorders and Stroke (NINDS), the National Institute on Aging of the National Institutes of Health (NIH), the Sherman Foundation Parkinson's Disease Research Challenge Fund, and internal funding from the Houston Methodist Research Institute. This groundbreaking research highlights the potential for new treatments and the importance of understanding TDP43's multifaceted role in health and disease.
